Seo Jung-jin
SJ
Chairman of Celltrion Group
Seo Jung-jin
Chairman of Celltrion Group
About
Seo Jung-jin is the Chairman of Celltrion Group, a South Korean biopharmaceutical company he founded in 1999. He is credited with developing the world's first antibody biosimilar, Remsima. Seo is currently leading Celltrion's strategic shift from a biosimilar manufacturer to a developer of novel drugs. He returned to management in March 2023 after a brief departure.
Score Breakdown
15Influence
0Track Record
35Visibility
2Profile
50Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
Who is Seo Jung-jin?
Seo Jung-jin is the Chairman of Celltrion Group, a South Korean biopharmaceutical company he founded in 1999. He is credited with developing the world's first antibody biosimilar, Remsima. Seo is currently leading Celltrion's strategic shift from a biosimilar manufacturer to a developer of novel drugs. He returned to management in March 2023 after a brief departure.
What is Seo Jung-jin's current role?
Seo Jung-jin is currently Chairman of Celltrion Group.
Contact Info
Similar People